Epigenetic aging of mammalian gametes
Molecular Reproduction and Development · 2023-12 · 90 (12) · 785-803
DOI: 10.1002/mrd.23717 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Reproduction and Development, online erschienen am 24.11.2023. Verfasst von Michael Klutstein und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical and Oral Research, Faculty of Dental Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel. Hauptthemen laut MEDLINE: Histones, Heterochromatin. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 243 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: United States-Israel Binational Science Foundation, Israeli Science Foundation, H2020 European Research Council.
Abstract (Originalsprache)
The process of aging refers to physiological changes that occur to an organism as time progresses and involves changes to DNA, proteins, metabolism, cells, and organs. Like the rest of the cells in the body, gametes age, and it is well established that there is a decline in reproductive capabilities in females and males with aging. One of the major pathways known to be involved in aging is epigenetic changes. The epigenome is the multitude of chemical modifications performed on DNA and chromatin that affect the ability of chromatin to be transcribed. In this review, we explore the effects of aging on female and male gametes with a focus on the epigenetic changes that occur in gametes throughout aging. Quality decline in oocytes occurs at a relatively early age. Epigenetic changes constitute an important part of oocyte aging. DNA methylation is reduced with age, along with reduced expression of DNA methyltransferases (DNMTs). Histone deacetylases (HDAC) expression is also reduced, and a loss of heterochromatin marks occurs with age. As a consequence of heterochromatin loss, retrotransposon expression is elevated, and aged oocytes suffer from DNA damage. In sperm, aging affects sperm number, motility and fecundity, and epigenetic changes may constitute a part of this process. 5 methyl‐cytosine (5mC) methylation is elevated in sperm from aged men, but methylation on Long interspersed nuclear elements (LINE) elements is reduced. Di and trimethylation of histone 3 lysine 9 (H3K9me2/3) is reduced in sperm from aged men and trimethylation of histone 3 lysine 27 (H3K27me3) is elevated. The protamine makeup of sperm from aged men is also changed, with reduced protamine expression and a misbalanced ratio between protamine proteins protamine P1 and protamine P2. The study of epigenetic reproductive aging is recently gaining interest. The current status of the field suggests that many aspects of gamete epigenetic aging are still open for investigation. The clinical applications of these investigations have far‐reaching consequences for fertility and sociological human behavior.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedical and Oral Research, Faculty of Dental Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
- The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel.
- Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat Gan, Israel.
ORCID-Profile: Michael Klutstein
Förderung
- United States-Israel Binational Science Foundation
- Israeli Science Foundation
- H2020 European Research Council
Zitieren
APA
Klutstein, M., & Gonen, N. (2023). Epigenetic aging of mammalian gametes. Molecular Reproduction and Development, 90(12), 785-803. https://doi.org/10.1002/mrd.23717
Vancouver
Klutstein M, Gonen N. Epigenetic aging of mammalian gametes. Molecular Reproduction and Development. 2023;90(12):785-803. doi:10.1002/mrd.23717
BibTeX
@article{Klutstein2023,
author = {Klutstein, Michael and Gonen, Nitzan},
title = {Epigenetic aging of mammalian gametes},
journal = {Molecular Reproduction and Development},
year = {2023},
volume = {90},
number = {12},
pages = {785--803},
doi = {10.1002/mrd.23717}
}
EUVIMED